Protalix Biotherapeutics, Inc. (PLX) To Present At The Oppenheimer 15th Annual Israeli Conference And The Mixiii Israel Innovation Conference, Biomed
5/7/2014 9:23:58 AM
CARMIEL, Israel, May 7, 2014 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), today announced that Dr. David Aviezer, the Company's President and Chief Executive Officer, will present at the Oppenheimer 15th Annual Israeli Conference and the MIXiii Israel Innovation Conference, Biomed. Details regarding the conferences are as follows:
Help employers find you! Check out all the jobs and post your resume.
comments powered by